Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paola Meraviglia

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2020
Reply to Childs et alCristina Gervasoni, Paola Meraviglia, Dario Cattaneo
The Journal of Antimicrobial Chemotherapy|June 14, 2018
How relevant are the drug-drug interactions between antiretroviral boosted-based regimens and calcium channel blockers in real life?Dario Cattaneo, Tiziana Formenti, Noemi Astuti, et al.
AIDS (London, England)|June 2, 2021
When the absence of an interaction can become clinically relevantDario Cattaneo, Dario Bernacchia, Martina Beltrami, et al.
AIDS and Behavior|May 5, 2019
Association of HIV Infection with Epilepsy and Other Comorbid ConditionsDario Cattaneo, Andrea Giacomelli, Davide Minisci, et al.
Therapeutic Drug Monitoring|February 2, 2023
Tenofovir Plasma Trough Concentrations in People Living with HIV Treated with Tenofovir Disoproxyl Fumarate: Antiretroviral Class or Individual Drug Effect?Dario Cattaneo, Stefano Bonora, Paola Meraviglia, et al.
The Journal of Antimicrobial Chemotherapy|March 17, 2021
Lack of clinically relevant interactions between bictegravir and metformin in persons with diabetes and HIVDario Cattaneo, Tiziana Formenti, Davide Minisci, et al.
Fundamental & Clinical Pharmacology|January 8, 2011
Atypical pharmacokinetics of atazanavir in an HIV-1-infected patientDario Cattaneo, Paola Meraviglia, Valeria Cozzi, et al.
The Journal of Antimicrobial Chemotherapy|January 10, 2013
Tenofovir plasma concentrations in post-menopausal versus pre-menopausal HIV-infected womenCristina Gervasoni, Paola Meraviglia, Simona Landonio, et al.
International Journal of Pharmaceutics|September 5, 2016
When food can make the difference: The case of elvitegravir-based co-formulationDario Cattaneo, Sara Baldelli, Davide Minisci, et al.
Antiviral Therapy|January 5, 2018
The relevance of drug-drug interactions in clinical practice: the case of concomitant boosted protease inhibitors plus alpha-1 blocker administrationCristina Gervasoni, Chiara Resnati, Tiziana Formenti, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2020
Reply to Childs et alCristina Gervasoni, Paola Meraviglia, Dario Cattaneo
The Journal of Antimicrobial Chemotherapy|June 14, 2018
How relevant are the drug-drug interactions between antiretroviral boosted-based regimens and calcium channel blockers in real life?Dario Cattaneo, Tiziana Formenti, Noemi Astuti, et al.
AIDS (London, England)|June 2, 2021
When the absence of an interaction can become clinically relevantDario Cattaneo, Dario Bernacchia, Martina Beltrami, et al.
AIDS and Behavior|May 5, 2019
Association of HIV Infection with Epilepsy and Other Comorbid ConditionsDario Cattaneo, Andrea Giacomelli, Davide Minisci, et al.
Therapeutic Drug Monitoring|February 2, 2023
Tenofovir Plasma Trough Concentrations in People Living with HIV Treated with Tenofovir Disoproxyl Fumarate: Antiretroviral Class or Individual Drug Effect?Dario Cattaneo, Stefano Bonora, Paola Meraviglia, et al.
The Journal of Antimicrobial Chemotherapy|March 17, 2021
Lack of clinically relevant interactions between bictegravir and metformin in persons with diabetes and HIVDario Cattaneo, Tiziana Formenti, Davide Minisci, et al.
Fundamental & Clinical Pharmacology|January 8, 2011
Atypical pharmacokinetics of atazanavir in an HIV-1-infected patientDario Cattaneo, Paola Meraviglia, Valeria Cozzi, et al.
The Journal of Antimicrobial Chemotherapy|January 10, 2013
Tenofovir plasma concentrations in post-menopausal versus pre-menopausal HIV-infected womenCristina Gervasoni, Paola Meraviglia, Simona Landonio, et al.
International Journal of Pharmaceutics|September 5, 2016
When food can make the difference: The case of elvitegravir-based co-formulationDario Cattaneo, Sara Baldelli, Davide Minisci, et al.
Antiviral Therapy|January 5, 2018
The relevance of drug-drug interactions in clinical practice: the case of concomitant boosted protease inhibitors plus alpha-1 blocker administrationCristina Gervasoni, Chiara Resnati, Tiziana Formenti, et al.
Pageof 7